- Quipt Home Medical, a medical supply company, has made the preliminary list to join the Russell 2000 and 3000 indexes
- The company is slated to join the indexes at the conclusion of the annual reconstitution, which is effective after the U.S. market open on June 26, 2023
- Management views the inclusion as a potential catalyst toward greater visibility and access to the global investment community
- Quipt Home Medical is a U.S.-based home medical supply company focused on chronic disease management and end-to-end respiratory care
- Quipt Home Medical (TSXV:QIPT) last traded at $7.70 per share
Quipt Home Medical, a medical supply company, has made the preliminary list to join the Russell 2000 and 3000 indexes.
The company is slated to join the indexes at the conclusion of the annual reconstitution, which is effective after the U.S. market open on June 26, 2023.
The annual Russell indexes reconstitution will capture the 4,000 largest U.S. stocks as of April 28, 2023, ranked by total market capitalization.
Membership in the U.S. all-cap Russell 3000 index remains in place for one year and entails automatic inclusion into the large-cap Russell 1000 index or small-cap Russell 2000 index, as well as the appropriate growth and value indexes.
FTSE Russell determines index inclusion based on objective, market capitalization, and style attributes.
“Being included in the Russell 2000 and 3000 indexes would be an affirmation of our strategic journey and a testament to the relentless efforts of our team. We remain committed to delivering sustained value to our shareholders and are thrilled by the idea of being included with some of the most forward-thinking companies in the United States, which we believe would considerably increase our visibility and access to the worldwide investment community,” stated Greg Crawford, Quipt’s CEO and Chairman.
“This inclusion would truly reflect the substantial growth experienced by our company and our evolution as a publicly traded company over the last several years. We are extremely well positioned to continue executing on our growth strategy, which has yielded robust and consistent financial performance, and we look forward to providing our shareholders with updates as we progress on our future vision,” he added.
Quipt Home Medical is a U.S.-based home medical supply company focused on chronic disease management and end-to-end respiratory care.
Quipt Home Medical (TSXV:QIPT) last traded at $7.70 per share.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
